SLT Laser Eye Surgery - What To Expect

SLT Laser Eye Surgery - What To Expect After Eye Surgery? SLT Post Eye Surgery for Glaucoma with Laser Eye Surgery. Laser eye surgery after care before and after. Glaucoma laser eye surgery,

Eye laser treatments like Lasik SLT & other LASER eye surgery procedures are performed by an ophthalmologist. What To Expect After Eye Surgery - So what happens during SLT laser eye surgery?
Selective Laser Trabeculoplasty (SLT) glaucoma laser eye surgery is a painless procedure that takes an Ophthalmologist only a few minutes, & provides several benefits over conventional treatment for glaucoma. SLT glaucoma eye surgery success rate is typically up to 85% & the least complex types of laser eye surgery, but unlike other glaucoma surgery, post eye surgery precautions doesn't apply after SLT glaucoma laser eye surgery, unless specified by the ophthalmologist or optometrist. All laser surgery for glaucoma has potential side effects but the benefits of maintaining good eyesight heavily outweigh any risk of surgery problems.

Up until 48 hours after my laser eye surgery, the pupil of my eye remained very small until the procedure had sufficient recovery time. Blurred vision could be one of a number of side effects you may or may not experience (see data & links below). It's prudent to check prior to having SLT or any laser eye surgery or therapy, any cost that may be incurred with laser eye surgery or if it is covered by Medicare or your private health fund.

Eye disease glaucoma & SLT laser surgery;

Selective laser trabeculoplasty is a laser treatment to treat glaucoma. It was initially indicated for open-angle glaucoma but has been proven to be efficacious for various types of glaucoma. This review article summarizes the few rare complications that can be seen with selective laser trabeculoplasty.

Glaucoma is an optic neuropathy in which intraocular pressures (IOPs) that are too high for the eye can result in optic nerve damage, subsequently leading to peripheral or central visual field loss. Modes of treatment include medications, laser, or intraocular surgery.

Selective laser trabeculoplasty (SLT) was developed in 1999 by Latina and Park2 as an alternative to ALT. SLT is a laser treatment that can reduce IOP in patients with open-angle glaucoma (OAG). SLT has a very short pulse duration (3 ns), which is shorter than the thermal relaxation time of melanin, allowing for selective photothermolysis. Because SLT selectively targets the pigmented TM cells and has an energy level 1% of ALT, it is a gentler laser than ALT with no histologic scarring or coagulative damage to the TM,3,4 thus reducing collateral damage to surrounding tissues and making repeat treatments possible. The incidence of iritis and elevated IOP is much lower compared to ALT.5

Indications
SLT has a variable success rate (40%–70%) in adults.6–8 SLT has been shown to be safe in adults,9 and the complication rate is extremely low.

The mechanism of action of SLT is not fully understood, although it is believed that it is more cellular and less mechanical or thermal,22 with macrophages from the spleen recruited into the TM via cytokines to remove debris from the TM.23 Histological studies have demonstrated minimal coagulative or mechanical damage.3,22,24 The TM following SLT was intact except for cracks in the corneoscleral sheets and a few endothelial cells with disrupted intracytoplasmic pigment granules and vacuoles.3,24 There is also evidence of TM cell division following both ALT and SLT.25,26
There is controversy whether SLT efficacy decreases with the use of concomitant prostaglandins. One study27 reported a 7% drop in IOP vs 20% drop in IOP when not taking prostaglandins. Another study28found that the success rate of SLT was 78.6% at 1 year in patients who were on combined dorzolamide–timolol and only 50% in patients who were on prostaglandins (P=0.041). Schlemm canal cells exposed to media conditioned by L cells that had been exposed to SLT or prostaglandin analogs demonstrated similar cell junction disassembly, whereas the cells exposed to nonprostaglandin analogs (brimonidine, timolol, and dorzolamide) did not show cell junction disassembly.29 This implies a similar mechanism of action between prostaglandins and SLT. The poorer success of SLT in patients on prostaglandins may suggest similar mechanisms of action of SLT and prostaglandins and that these two treatment methods may compete with one another. ALT use declined with the advent of prostaglandins for glaucoma therapy. Perhaps the decline in ALT efficacy in the 1990s was due to the minimal efficacy as a result of competition between prostaglandins and ALT.

End music mix : Steve Mack
(C) Steve Mack

[SteveMack]

* Just a very delayed update: I did have the other eye done a few months later, with no problems. The pressure in both eyes very soon after was nice and low, which is ideal. I still use Lumigan eye drops nightly, to further keep pressurws down, which avoids optic nerve damage.🙂👍

[billlowe]

Many thanks for the information. Having the surgery next week. No worries now.

[kaililkendrick]

Just watched your things to do in 5 seconds, excellent work sir. Sub earned. Hope your eyes get better soon

[OutandAboutwithCraig]

I’m glad your laser surgery was a success. I did enjoy watching this video of you explaining the procedure before and after. Sorry to hear about the little prick (pin prick) you received. 😮

[petraeva]

Just came across this video. Thank you for this down-to-earth explanation of the procedure. I am scheduled for mid July. i live in Germany and here they laser the entire eye, not just half. Day one, one half, next day pressure check then second half of eye.

[SteveMack]

Useful info about eye disease glaucoma & SLT laser surgery;

[SteveMack]

Am having my right eye done tomorrow - At least I know what to expect this time, so am not concerned 👍

[johnnyduplantis]

10:10 Is that an example of a Freudian slip?